Kinetics and dosing predictions for daily haemofiltration

Area of Science:

• Nephrology
• Renal Replacement Therapy
• Biomedical Engineering

Background:

• Chronic renal failure (CRF) management often involves thrice-weekly haemofiltration.
• Daily haemofiltration (DHF) presents a more intensive therapeutic option for CRF.
• Adequate solute clearance requirements for DHF are not well-defined.

Purpose of the Study:

• To theoretically evaluate solute kinetic profiles during DHF.
• To compare DHF solute clearances with high-flux haemodialysis (HFHD) and continuous ambulatory peritoneal dialysis (CAPD).
• To determine optimal exchange volumes for DHF therapy.

Main Methods:

• Theoretical solute kinetic profiles were calculated for DHF, HFHD, and CAPD using a two-compartment model.
• Five solutes (urea, creatinine, vitamin B12, inulin, beta2-microglobulin) were analyzed.
• Calculations compared DHF (15L/session) with HFHD (urea Kt/V 3.6/week) and CAPD (urea Kt/V 2.0/week).

Main Results:

• DHF with 90L/week exchange volume demonstrated equivalent urea clearance to HFHD and CAPD based on urea stdKt/V.
• Middle molecule clearances during DHF surpassed those of HFHD and CAPD.
• DHF showed inferior urea clearance but superior middle molecule clearance compared to short daily haemodialysis (SDHD).

Conclusions:

• Approximately 40% of total body water exchange volume per DHF session is predicted to ensure adequate small solute and substantial middle molecule clearance.
• These theoretical findings highlight DHF's potential for enhanced solute removal in CRF.
• Clinical validation of these theoretical predictions is necessary.